Assessing efficacy and safety of Tuina for patellofemoral osteoarthritis: a randomized clinical trial
Frontiers in Medicine · 20.11.2026 · 13
DOI: 10.3389/fmed.2026.1966393 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Medicine, online erschienen am 20.11.2026. Verfasst von Hui Xu und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study evaluated the effectiveness and safety of Tuina for patients with patellofemoral osteoarthritis (PFOA).
Methods
We randomly assigned 108 patients with PFOA to either an observation group or a control group. Both groups received standardized health education, and the observation group additionally received a Tuina intervention. The intervention period lasted two weeks. We collected data on muscle strength, pain, and function at baseline, week 1, week 2, follow-up 1, and follow-up 2. The primary outcomes were lower limb flexion and extension muscle strength and the pressure pain threshold (PPT) at the patellar margin. Secondary outcomes included the modified 30-second sit-to-stand test (m30STS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score. Additional measures were the patient satisfaction rate and the incidence of adverse reactions.
Results
The observation group showed significantly greater gains in knee extensor strength at week 1, week 2, and the 15-day follow-up ( P < 0.001), with no significant between-group difference at day 30 ( P > 0.05). Knee flexor strength was significantly higher than controls across all timepoints ( P < 0.001). For PPT site I, both groups improved over time without significant differences ( P > 0.05). Between-group differences favouring Tuina were observed at site II throughout the trial ( P < 0.05); at site III only during treatment weeks ( P < 0.05); at site IV during follow-up phases ( P < 0.001); at site V at week 2 ( P < 0.001); and at site VI at week 1, week 2 and day 30 ( P < 0.05). m30STS gains were significantly greater in the observation group ( P < 0.05). WOMAC scores decreased significantly in both arms, with no significant difference ( P > 0.05). Treatment satisfaction was significantly higher for Tuina ( P < 0.05), and no severe adverse events occurred in either group.
Conclusions
Tuina combined with health education may improve lower limb muscle strength, alleviate pain sensitivity, and enhance knee joint function in patients with PFOA, with good tolerability and patient satisfaction.
Zitieren
APA
Xu, H., Yang, F., Chen, J., Zhao, C., Fan, X., Li, M., Zhou, Y., & Shi, M. (2026). Assessing efficacy and safety of Tuina for patellofemoral osteoarthritis: a randomized clinical trial. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1966393
Vancouver
Xu H, Yang F, Chen J, Zhao C, Fan X, Li M, et al. Assessing efficacy and safety of Tuina for patellofemoral osteoarthritis: a randomized clinical trial. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1966393
BibTeX
@article{Xu2026,
author = {Xu, Hui and Yang, Fangli and Chen, Juntao and Zhao, Chi and Fan, Xuanqiang and Li, Mengmeng and Zhou, Yunfeng and Shi, Mingwei},
title = {Assessing efficacy and safety of Tuina for patellofemoral osteoarthritis: a randomized clinical trial},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1966393}
}
EUVIMED